bioRxivPharmacology & Toxicology
Hijacking Methyl Reader proteins for Nuclear-Specific Protein Degradation
Abstract
Targeted protein degradation (TPD) by PROTACs is a promising strategy to control disease-causing protein levels within the cell. While TPD is emerging as an innovative drug discovery paradigm, there are currently only a limited number of E3 ligase: ligand pairs that are employed to induce protein degradation. Herein, we report a novel approach to induce protein degradation by hijacking a methyl reader: E3 ligase complex. L3MBTL3 is a methyl lysine reader protein that binds to the Cul4DCAF5 E3 ligase complex and targets methylated proteins for proteasomal degradation. By co-opting this natural mechanism, we report the design and biological evaluation of L3MBTL3-recruiting PROTACs and demonstrate nuclear-specific degradation of FKBP12 and BRD2. We envision this as a generalizable approach to utilize other reader protein-associated E3 ligase complexes in PROTAC design to expand the E3 ligase toolbox and explore the full potential of TPD.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications
N. J. Henning, A. G. Manford, … D. K. Nomura·bioRxiv·Apr 15, 2021
- Temporal and Spatial Characterization of CUL3KLHL20-driven Targeted Degradation of BET family, BRD Proteins by the Macrocycle-based Degrader BTR2004
Phoebe H. Fechtmeyer, Cameron Martinez, Johannes T.‐H. Yeh·ACS Chemical BiologyPeer-reviewed·Sep 2, 2025
- Targeted Protein Degradation through E2 Recruitment
N. Forte, D. Dovala, … D. K. Nomura·bioRxiv·Dec 19, 2022
- Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation
S. H. Hong, A. Osa, … D. Nomura·bioRxiv·Oct 20, 2023
- Targeted Protein Degradation by KLHDC2 Ligands Identified by High Throughput Screening
Han Zhou, Tonglian Zhou, … Michael J. Bollong·bioRxiv·Mar 31, 2025
- ByeTAC: Bypassing an E3 Ligase for Targeted Protein Degradation
E. M. Ali, C. Loy, D. J. Trader·bioRxiv·Jan 20, 2024